1. Home
  2. ZURA vs SFWL Comparison

ZURA vs SFWL Comparison

Compare ZURA & SFWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • SFWL
  • Stock Information
  • Founded
  • ZURA 2022
  • SFWL 2001
  • Country
  • ZURA United States
  • SFWL China
  • Employees
  • ZURA N/A
  • SFWL N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • SFWL Trucking Freight/Courier Services
  • Sector
  • ZURA Health Care
  • SFWL Industrials
  • Exchange
  • ZURA Nasdaq
  • SFWL Nasdaq
  • Market Cap
  • ZURA 69.9M
  • SFWL 82.3M
  • IPO Year
  • ZURA N/A
  • SFWL 2023
  • Fundamental
  • Price
  • ZURA $2.04
  • SFWL $1.12
  • Analyst Decision
  • ZURA Buy
  • SFWL
  • Analyst Count
  • ZURA 10
  • SFWL 0
  • Target Price
  • ZURA $12.67
  • SFWL N/A
  • AVG Volume (30 Days)
  • ZURA 367.0K
  • SFWL 30.0K
  • Earning Date
  • ZURA 08-14-2025
  • SFWL 08-27-2025
  • Dividend Yield
  • ZURA N/A
  • SFWL N/A
  • EPS Growth
  • ZURA N/A
  • SFWL 31.68
  • EPS
  • ZURA N/A
  • SFWL 0.14
  • Revenue
  • ZURA N/A
  • SFWL $540,461,000.00
  • Revenue This Year
  • ZURA N/A
  • SFWL N/A
  • Revenue Next Year
  • ZURA N/A
  • SFWL N/A
  • P/E Ratio
  • ZURA N/A
  • SFWL $7.47
  • Revenue Growth
  • ZURA N/A
  • SFWL 21.10
  • 52 Week Low
  • ZURA $0.97
  • SFWL $0.86
  • 52 Week High
  • ZURA $5.07
  • SFWL $1.60
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 65.78
  • SFWL 56.66
  • Support Level
  • ZURA $1.44
  • SFWL $1.00
  • Resistance Level
  • ZURA $2.09
  • SFWL $1.29
  • Average True Range (ATR)
  • ZURA 0.14
  • SFWL 0.08
  • MACD
  • ZURA 0.03
  • SFWL 0.01
  • Stochastic Oscillator
  • ZURA 78.31
  • SFWL 41.31

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About SFWL Shengfeng Development Limited

Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services.

Share on Social Networks: